Advertisement

Advertisement

Most Read Stories
CLEOPATRA End-of-Study Analysis in Metastatic Breast Cancer: 37% Alive at 8 Years
Winning the Lottery
APACT Trial: Nab-paclitaxel/Gemcitabine vs Gemcitabine Alone in Adjuvant Treatment of Pancreatic Cancer
Long-Term Results of the Omission of Postoperative Radiation to the Pathologically Node-Negative Neck in Primary HNSCC
ReDOS: Regorafenib Dose-Escalation Strategy in Refractory Advanced Colorectal Cancer
ESMO World GI 2019: BEACON CRC: Encorafenib/Binimetinib/Cetuximab Improves Survival in BRAF V600E–Mutated Metastatic Colorectal Cancer
Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events
Combination Immunotherapy and Inhibitors of DNA Damage Repair in the Treatment of Small Cell Lung Cancer
GOG-0218: Final Overall Survival Results for Addition of Bevacizumab to Chemotherapy in Ovarian Cancer
Management of HER2-Positive Breast Cancer: Business as Usual?
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
NALA Trial: Neratinib Plus Capecitabine Shows Benefit in Metastatic Breast Cancer
ESMO World GI 2019: Incidence of Gastric Cancer in Younger Individuals
Study Identifies Key Biologic Features of Upper Tract Urothelial Carcinoma
FDA Pipeline: Designations and Applications Granted in Lymphoma, Small Cell Lung Cancer, Multiple Myeloma, and More
ESMO World GI 2019: REARRANGE Trial Examines Flexible Regorafenib Dosing in Refractory Metastatic Colorectal Cancer
Does Radioactive Iodine Treatment for Hyperthyroidism Increase the Risk of Cancer Mortality?
Biden Cancer Initiative Suspends All Operations
Cost-Effectiveness of Single-Marker Genetic Testing vs Multigene Panel Sequencing in Advanced NSCLC

Advertisement

Advertisement



;
Advertisement